Little Green Pharma (ASX:LGP) signed a binding sale and purchase agreement to acquire HHI (Australia), owner of the Health House medicinal cannabis distribution business, for AU$375,000, according to a Wednesday filing with the Australian bourse.
The company will absorb Health House's estimated AU$350,000 net liability position once the deal is completed.
Health House's ultimate parent company, Melodiol Global Health, had listed the business for sale at AU$10.9 million in September 2024.
The acquisition is expected to close Wednesday, the filing said.
The ASX-listed medicinal cannabis company's shares rose nearly 5% in recent Wednesday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。